Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 21471211)


Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions.

Naimy H, Buczek-Thomas JA, Nugent MA, Leymarie N, Zaia J.

J Biol Chem. 2011 Jun 3;286(22):19311-9. doi: 10.1074/jbc.M110.204693. Epub 2011 Apr 6.


Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing.

Sterner E, Masuko S, Li G, Li L, Green DE, Otto NJ, Xu Y, DeAngelis PL, Liu J, Dordick JS, Linhardt RJ.

J Biol Chem. 2014 Apr 4;289(14):9754-65. doi: 10.1074/jbc.M113.546937. Epub 2014 Feb 22.


Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling.

Jastrebova N, Vanwildemeersch M, Lindahl U, Spillmann D.

J Biol Chem. 2010 Aug 27;285(35):26842-51. doi: 10.1074/jbc.M109.093542. Epub 2010 Jun 24.


Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.

Jastrebova N, Vanwildemeersch M, Rapraeger AC, Giménez-Gallego G, Lindahl U, Spillmann D.

J Biol Chem. 2006 Sep 15;281(37):26884-92. Epub 2006 Jun 28.


Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.

Zhang F, Zhang Z, Lin X, Beenken A, Eliseenkova AV, Mohammadi M, Linhardt RJ.

Biochemistry. 2009 Sep 8;48(35):8379-86. doi: 10.1021/bi9006379.


Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.

Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A.

J Biol Chem. 1994 Jan 7;269(1):114-21.


Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.

Staples GO, Shi X, Zaia J.

J Biol Chem. 2010 Jun 11;285(24):18336-43. doi: 10.1074/jbc.M110.101592. Epub 2010 Apr 2.


Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.

Ashikari-Hada S, Habuchi H, Sugaya N, Kobayashi T, Kimata K.

Glycobiology. 2009 Jun;19(6):644-54. doi: 10.1093/glycob/cwp031. Epub 2009 Mar 2.


A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.

Mohammadi M, Olsen SK, Goetz R.

Curr Opin Struct Biol. 2005 Oct;15(5):506-16. Review.


Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.

Allen BL, Filla MS, Rapraeger AC.

J Cell Biol. 2001 Nov 26;155(5):845-58. Epub 2001 Nov 26.


Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.

Casu B, Naggi A, Torri G.

Matrix Biol. 2010 Jul;29(6):442-52. doi: 10.1016/j.matbio.2010.04.003. Epub 2010 Apr 21. Review.


Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.

Loo BM, Kreuger J, Jalkanen M, Lindahl U, Salmivirta M.

J Biol Chem. 2001 May 18;276(20):16868-76. Epub 2001 Feb 21.


Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.

Guglier S, Hricovíni M, Raman R, Polito L, Torri G, Casu B, Sasisekharan R, Guerrini M.

Biochemistry. 2008 Dec 30;47(52):13862-9.


Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides.

Guimond SE, Turnbull JE.

Curr Biol. 1999 Nov 18;9(22):1343-6.


FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.

Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn CM, Waksman G.

Science. 1995 Apr 21;268(5209):432-6.


Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.

Kato M, Wang H, Bernfield M, Gallagher JT, Turnbull JE.

J Biol Chem. 1994 Jul 22;269(29):18881-90.


Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.

Hu Y, Guimond SE, Travers P, Cadman S, Hohenester E, Turnbull JE, Kim SH, Bouloux PM.

J Biol Chem. 2009 Oct 23;284(43):29905-20. doi: 10.1074/jbc.M109.049155. Epub 2009 Aug 20.


Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.

Ibrahimi OA, Zhang F, Hrstka SC, Mohammadi M, Linhardt RJ.

Biochemistry. 2004 Apr 27;43(16):4724-30.


Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.

Naimy H, Leymarie N, Zaia J.

Biochemistry. 2010 May 4;49(17):3743-52. doi: 10.1021/bi100135d.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk